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Edited by Felix WielandAbstract Mst3, a human Ste20-like protein kinase, has been
recently demonstrated to undergo a caspase-mediated cleavage
during apoptosis. The proteolytic cleavage of the C-terminus of
Mst3 caused nuclear translocation of its kinase domain. This
work provides evidence that Mst3 may contain a bipartite-like
nuclear localization sequence (NLS) at the C-terminus of its
kinase domain (residues 278–292). The removal of NLS from the
kinase domain of Mst3 led to the cytoplasmic accumulation of
EGFP-Mst3D277. The presence of nuclear exporting signals in
the Mst3 was also demonstrated by leptomycin B-treatment and
serial deletion of the C-terminal regulatory domain of Mst3. A
nuclear export signal was also postulated to be in the regions of
amino acids 335–386. In conclusion, Mst3 contains both NLS
and NES signals, which may cooperate to control the subcellular
distribution of Mst3.
 2004 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Ste20, a sensory protein kinase upstream in the MAP kinase
pathway, plays an important role in regulating the pheromone-
response pathway of budding yeast [1]. Twenty eight mam-
malian counterparts of Ste20 have been identiﬁed so far and
can be categorized into two main subfamilies, based on their
amino acid sequences and the physical location of their kinase
domains in the polypeptide chains. Each p21-Rac/Cdc42 ac-
tivated kinase (PAK) family member contains a kinase domain
at its C-terminus, while its N-terminal regulatory domain has a
binding site for a small GTPase [2]. The germinal center kinase
(GCK) family, however, has an N-terminal kinase domain and
a C-terminal regulatory domain [3]. The Mst (mammalian
SPS1/Ste20-like) protein kinases, Mst1, -2, -3, and -4, are
members of this latter subfamily [3–8]. Based on the similarity
between the sequences inside and outside their kinase domains,* Corresponding author. Fax: +886-3-572-9288.
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Abbreviations: GFP, green ﬂuorescence protein; Mst, mammalian
Ste20-like protein kinase; NLS, nuclear localization sequence; NES,
nuclear exporting signal; LMB, leptomycin B
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C. elegant orthologs, the Mst family kinases can be further
divided into the GCK-II subgroup (Mst1 and Mst2) and the
GCK-III subgroup (Mst3 and Mst4) [9].
Mst3 was recently shown to undergo caspase-mediated
proteolytic cleavage during apoptosis [10]. Cleavage of Mst3
by caspases yields two fragments, Mst3/N and Mst3/C, with
sizes of around 35 and 15 kDa, respectively. The Asp313 was
identiﬁed later to be the cutting site for caspases. Interestingly,
the removal of the C-terminus by mutagenesis results in nu-
clear translocation of the Mst3WTD314. This observation sup-
ports the hypothesis that the Mst3WTD314 may contain a
nuclear localization sequence (NLS), which is exposed upon
caspase cleavage and may be a prerequisite for its role in ap-
optosis. The presence of a putative nuclear export signal (NES)
in the C-terminal regulatory domain of Mst3 has also been
postulated [10].
This study shows that Mst3 contained both NLS and NES
signals. TheNLS is present at the C-terminus of theMst3 kinase
domain, whereas the C-terminal regulatory domain contains at
least one NES signal. The evidence presented in this work fur-
ther reveals that the dynamic subcellular distribution of Mst3
can be mediated by coordination between these two signals.2. Materials and methods
2.1. Materials
Restriction enzymes were purchased from New England Bio-Labs.
Fetal bovine serum (FBS), Dulbecco’s modiﬁed eagle’s medium
(DMEM), penicillin G, streptomycin, and Lipofectamine were ob-
tained from Life Technologies. Leptomycin B (LMB) was obtained
from Roche. The oligonucleotides were synthesized by BioBasic Inc.,
UK. All other reagents used were of reagent grade.
2.2. Cell lines and cell culture
The human cervical carcinoma cell line (HeLa) was maintained in
DMEM containing 10% FBS, 100 units/ml penicillin, and 100 lg/ml
streptomycin. Cells were incubated in a humidiﬁed 37 C incubation
chamber that contained 5% CO2. The cells were transiently transfected
using LipofectamineTM as directed by the manufacturer (GIBCO Life
Technologies).
2.3. Plasmid construction and site-directed mutagenesis
As shown in Fig. 1, Mst3 deletion mutants, including Mst3WTD417
(residues 1–416), Mst3WTD386 (residues 1–385), Mst3WTD337 (residues 1–
336), Mst3WTD295 (residues 1–294), and Mst3WTD278 (residues 1–277), as
well as Mst3 fragments, such as Mst3312–431 (residues 312–431),
Mst3335–431 (residues 335–431), and Mst3385–416 (residues 385–416),blished by Elsevier B.V. All rights reserved.
Fig. 1. EGFP-tagged wild-type Mst3 and its mutants. NLS is the proposed nuclear localization sequence of Mst3.
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with a stop-codon added to their 30-end, were inserted into the
pEGFP-C2 vector (CLONTECH) between HindIII and EcoRI sites.
The NLS-deﬁcient mutants of Mst3WTD314, Mst3D314ð278A=279AÞ (with
K278 and K279 replaced by Ala), Mst3D314ð291A=292AÞ (with K291 and
R292 replaced by Ala), and Mst3D314ð4AÞ (with K278, K279, K291, and
R292 replaced by Ala), were generated according to the QuikChan-
geTM Site-Directed Mutagenesis protocol (Stratagene). The primers
50-CGACAGGTACGCGGCATGGAAG-30 and 50-CGGCCTTCC-
ATGCCGCGTACCTGTCG-30 were used to yield Mst3D314ð291A=292AÞ.
The primers 50-CTACGCAATGCAGCGGCAACTTCCTACTTGA-
CCG-30 and 50-CGGTCA-AGTAGGAAGTTGCCGCTGCATTG-
CGTAG-30 were used to obtain Mst3D314ð278A=279AÞ. The DNA
sequences of subcloned cDNAs were conﬁrmed using an automatic
DNA sequencer ABI-377 (Perkin–Elmer).
2.4. Fluorescence microscopy
The location of the EGFP in living cells was monitored using an
inverted ﬂuorescence microscope (Leica DELM model). The HeLa
cells were cultured in a 35 mm cultural dish with a sterilized cover
glass. After transfection and recovery for 18 h, cells were ﬁxed with 4%
paraformaldehyde in pH 7.4 phosphate buﬀer saline at 4 C for 20 min.
To counterstain the nucleus, the paraformaldehyde-ﬁxed cells were
treated with 0.2% Triton X-100 at 4 C for 20 min and then stained
with 200 ng/ml DAPI (40,60-diamidino-2-phenylindole) at 4 C for 20
min. The raw photographic images were acquired using a Kodak
digital camera and processed with Free PLUS software (Media Cy-
bernetics, Silver Spring, MD, USA). Each experiment was conducted
under the same conditions at least twice.3. Results
3.1. Identiﬁcation of NLS in Mst3
An earlier work has shown that the C-terminus-truncated
Mst3 mutant, Mst3WTD314, exhibits nuclear translocation [10].
Upon sequence alignment, a short basic residue-rich region,
278KKTSYLTELIDRYKRWK294, in Mst3 was found to re-
semble the bipartite-type NLS [11,12]. To verify that this se-
quence is indeed the NLS, EGFP-tagged Mst3WT, Mst3WTD314,
Mst3WTD295, and Mst3WTD278 (Fig. 1) were transiently ex-
pressed in 293T cells. As expected, EGFP-Mst3WTD295, like
EGFP-Mst3WTD314, was present in the nucleus, whereas
EGFP-Mst3WT and EGFP-Mst3WTD278 were mostly distrib-
uted in the cytoplasm (Fig. 2A). The EGFP alone was found tobe distributed in both the cytoplasm and the nucleus (Fig. 2A),
probably because a small protein such as EGFP (about 26
kDa) can slip through the nuclear pores by passive diﬀusion.
These results reveal that the NLS of Mst3 may be present in
the region between amino acids 278 and 294.
Bipartite NLS is characterized by two basic-residue clusters
in the sequence. When the key residues in proposed NLS,
Lys278, Lys279, Lys291, and Arg292, were changed to Ala by
site-directed mutagenesis (Table 1), most EGFP-Mst3D314ð4AÞ
was found to be present in the cytoplasm (Fig. 2B), whereas
partial mutation of NLS caused impaired nuclear localization
of Mst3D314ð278A=279AÞ and Mst3D314ð291A=292AÞ (Fig. 2B and
Table 1). These results reveal that the Mst3 contains a NLS
that is most likely located between amino acids 278 and 292.
Although the involvement of K294 is unknown, it may make
little or no contribution to the NLS, according to the results in
Fig. 2B and Table 1.3.2. Leptomycin B inhibits nuclear export of Mst3
Several lines of evidence demonstrate that nucleocytoplas-
mic translocation of proteins can be mediated by both NLS
and NES signals [13–16]. Although NLS has been shown to be
a prerequisite for the nuclear localization of Mst3, the presence
of NES that mediates the cytoplasmic distribution of full-
length Mst3 cannot be ruled out. To examine this possibility,
the EGFP-Mst3WT transiently expressed-HeLa cells were
treated with 10 ng/ml LMB, an inhibitor of the Crm1-mediated
export. As shown in Fig. 3, the originally cytoplasmic-localized
EGFP-Mst3WT began to accumulate in the nucleus after LMB
treatment. This result suggests that Mst3 may contain a NES-
like sequence, which is functionally active and that the Crm1/
exprotin-dependent nuclear exporting mechanism may be re-
sponsible for the nuclear export of the full-length Mst3.3.3. NES controls the subcellular localization of Mst3
The amino acid sequence alignment revealed that the C-
terminal regulatory domain of Mst3 may contain two Leu/Ile-
rich sequences that are characteristic of NES signals (Fig. 4A).
Therefore, the C-terminal regulatory domain of EGFP-tagged
Fig. 2. NLS in Mst3 was revealed by deletion analysis. (A) HeLa cells transiently transfected with EGFP-Mst3WT, EGFP-Mst3WTD314, EGFP-
Mst3WTD295, or EGFP-Mst3WTD278, were monitored under a ﬂuorescent microscope. (B) HeLa cells transiently transfected with Mst3D314ð278A=279AÞ,
Mst3D314ð291A=292AÞ, or Mst3D314ð4AÞ were monitored under a ﬂuorescent microscope. Nuclei were stained with DAPI following transfection, as de-
scribed in Section 2.
Table 1
The subcellular distribution of Mst3 mutants
EGFP-Mst3 mutants Amino acid sequencea Nucleus (N) or Cytoplasm (C)
Mst3-NLS 278KKTSYLTELIDRYKRWK294 N
Mst3D314ð278A=279AÞ AA C¼N
Mst3D314ð291A=292AÞ AA N>C
Mst3D314ð4AÞ AA AA C
aThe amino acid sequence of human Mst3 between residues 278 and 294 is shown. The basic residue clusters in NLS are underlined. N and C
represent the cellular location of Mst3 mutants in nucleus (N) and cytoplasm (C), respectively.
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HeLa cells. As shown in Fig. 4B, green ﬂuorescence began to
accumulate in the nucleus when the regions between amino
acids 386–416 and 337–385 were lost. This result demonstrates
that the C-terminal regulatory domain of Mst3 contains the
NES. To further identify the NES in Mst3, various EGFP-
tagged C-terminal fragments of Mst3 (Fig. 1) were constructed
and transiently expressed in the HeLa cells. Interestingly, a
signiﬁcant amount of the Mst3312–431- or Mst3335–431-tagged
EFGP was found to accumulate in the cytoplasm, while
Mst3385–416-tagged EGFP remained in the nucleus. These re-sults suggest that Mst3 may contain a NES, which is in the
region between amino acids 335 and 385.4. Discussion
Nucleocytoplasmic transport is an important process that
provides an opportunity for protein kinases to speciﬁcally
regulate genes and cellular functions by gaining controlled
access to their downstream targets in the nucleus [17,18]. The
calcium/CaM-dependent protein kinase IV (CaMK-IV), for
Fig. 4. Mst3 contains NES signals that promote its nuclear translo-
cation. (A) Comparison of proposed NES sequences with those in
protein kinase A inhibitor (PKI) [16], human immunodeﬁciency virus-
1 Rev protein (Rev) [15], kPKC [24], and Mst1 [25]. (B) HeLa cells
were transiently transfected with EGFP-Mst3WT, EGFP-Mst3WTD417,
EGFP-Mst3WTD386, EGFP-Mst3WTD337, EGFP-Mst3312–431, EGFP-
Mst3335–431, or EGFP-Mst3380–416. Eighteen hours after transfection,
cells were ﬁxed and stained with DAPI as described in Section 2. The
subcellualr distribution of Mst3 mutants was monitored by EGFP
ﬂuorescence.
Fig. 3. Eﬀect of LMB on the subcellular distribution of EGFP-
Mst3WT. HeLa cells, expressing EGFP-Mst3WT, were treated with
(+LMB) or without ()LMB) 10 ng/ml leptomycin B at 37 C for 1 h.
Cells were then ﬁxed and stained with DAPI. Observations were
made under a ﬂuorescence microscope. LMB treatment resulted in
the nuclear localization of EGFP-Mst3WT, as identiﬁed by EGFP
ﬂuorescence.
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cyclic AMP response element-binding protein (CREB) [19,20].
The nuclear translocation of p42/p44 MAPK is essential for
growth factor-induced DNA replication [21,22] and cell
transformation [23].
The bi-directional nuclear traﬃcking of proteins is usually
initiated by the recognition and association of nuclear trans-
port receptors, such as importins and Crm1, to short stretches
of amino acids known as the NLS [11–14] and the NES [13–
16,24,25] in the proteins ready to be transported. As shown
previously, removing the C-terminal regulatory domain of
Mst3 can change the subcellular distribution of Mst3 [10].
Although the molecular mechanism for the nuclear translo-
cation of Mst3 was unclear, the presence of the NLS was
postulated. The results of this work reveal that an NLS is
present at the C-terminus of Mst3 kinase domain. The prote-
olytic cleavage of Mst3 during apoptosis may expose the NLS
signal and subsequently mediate the translocation of truncated
Mst3 to the nucleus. Although no general consensus sequence
is present, NLS seems to be characterized by a cluster of basic
amino acids [12,26,27]. Upon amino acid alignment, a bipartite
type NLS that contains two basic-residue clusters [11,12] in
Mst3 is postulated. The mutation of the basic residues in the
NLS markedly aﬀected the subcellular distribution of Mst3 in
cells (Fig. 2B and Table 1).
Interestingly, the full-length Mst3 moved from the cyto-
plasm to the nucleus, when the cells were treated with LMB, an
inhibitor of the Crm1-mediated export process. This ﬁnding
suggests that Mst3 may contain a NES signal. This hypothesis
was demonstrated by studying the subcellular localization of
the C-terminal deletion mutants of Mst3 (Fig. 4). Upon amino
acid sequence alignment, the presence of two possible NESs in
the regions of amino acids 335–385 and 385–416 was postu-
lated (Fig. 4A). The region between residues 335 and 385 is
probably the one that contains NES, based on the C-terminal
deletion analysis of Mst3 (Fig. 4B). Although EGFP-Mst4D386
also accumulated in the nucleus, indicating that the residues
385–416 may contain an NES, this region did not exhibit NES
activity when fused with EGFP, perhaps because the EGFP-
Mst3D386 or the EGFP-Mst3385–416 does not fold properly.Therefore, the presence of an NES in the region 385–416 was
not established. Short stretch 364LSTIISPLFAEL375 was found
to be highly homologous to the known NES sequences
(Fig. 4A), so further investigations using site-directed muta-
genesis may help to determine the presence of NES in this
region.
In summary, Mst3 may contain both NLS and NES, which
may cooperate in mediating the dynamic subcellular distribu-
tion of Mst3 in cells. In the resting state, the NLS of wild-type
Mst3 may be shielded by the C-terminal regulatory domain.
Therefore, the NES dominates and keeps Mst3 out of the
nucleus. Only when caspase removes the C-terminal regulatory
domain of Mst3, the NLS exposed and the nuclear translo-
cation of Mst3 induced. Alternatively, the predominant cyto-
plasmic steady-state localization of inactive Mst3 may result
from the fact that the rate of nuclear export exceeds that of
import. Removing the regulatory domain that contains the
W.-S. Lee et al. / FEBS Letters 572 (2004) 41–45 45NESs with caspase cleavage simply shifts the equilibrium be-
tween the import and export of the kinase domain toward the
nuclear side. This assertion is demonstrated by the result that
the full-length Mst3 appears to shuttle continuously between
the nucleus and the cytoplasm, since LMB treatment promotes
nuclear accumulation (Fig. 3).
Mst3 has been shown to play an important role in triggering
apoptotic cell death. The nuclear localization of Mst3 may
promote cell apoptosis, as suggested by a previous work, in
which Mst3WTD314 induced more cell death than did Mst3WT
[10]. Crm1-mediated export not only provides a mechanism for
the cytoplasmic conﬁnement of full-length Mst3, but also
provides a means of spatially separating the active kinase do-
main from the regulatory domain during apoptosis. The
identiﬁcation and characterization of the NLS, and the eluci-
dation of potential NESs are important steps toward under-
standing the mechanism of Mst3 action.
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